Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 04, 2020
Charles River Laboratories announced the appointment of Nancy C. Andrews, M.D., Ph.D., to its Board of Directors, effective February 28, 2020.
read more
Wednesday, March 04, 2020
Among the concerns raised due to the impact of the novel coronavirus is whether patients can count on a reliable supply of medicine.
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more
ANI has received approval of the Company's ANDA from the FDA for Memantine Hydrochloride Extended-Release Capsules 7 mg, 14 mg, 21 mg and 28 mg.
read more
SIGA entered into a collaboration with Turnstone Biologics to provide TPOXX in connection with Turnstone’s proprietary SKV vaccinia oncolytic immunotherapy platform.
read more
Abpro announced the formation of a strategic partnership to advance two bispecific antibodies in key Asian markets including Greater China, Japan, and South Korea.
read more
ImprimisRx has agreed to a product supply agreement with Vision Center Network of America (VCNA).
read more
The FDA issued a new policy for certain laboratories seeking to develop diagnostic tests for coronavirus in order to achieve more rapid testing capacity in the U.S.
read more
PerkinElmer announced Michel Vounatsos has been elected to its board of directors, effective March 1, 2020.
read more
Boston-based Laboratory-as-a-Service (LaaS) leader, SmartLabs, has announced a national expansion with the addition of 80,000 square feet in South San Francisco, California.
read more
BioDuro has broadly launched new antibody- and cell-based therapy discovery services.
read more
Schrödinger has entered into a three-year agreement with Google Cloud to increase the speed and capacity of its physics-based computational platform for drug discovery.
read more
Takeda announced the completion of its previously-announced sale of a portfolio of select OTC and prescription pharmaceutical assets in a number of countries.
read more
Friday, February 28, 2020
Merck KGaA, Darmstadt, Germany and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets.
read more
Friday, February 28, 2020
The FDA has been closely monitoring the supply chain with the expectation that the COVID-19 outbreak would likely impact the medical product supply chain, including potential disruptions to supply or shortages of critical medical products in the U.S.
read more